Skin lesions in chronic myeloid leukemia patients during dasatinib treatment

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment

Francesco Tarantini,1 Luisa Anelli,1 Giuseppe Ingravallo,1 Immacolata Attolico,1 Antonella Zagaria,1 Antonella Russo Rossi,1 Lucia Lospalluti,2 Tamara Bufano,2 Giovanni Zanframundo,2 Eugenio Maiorano,1 Giorgina Specchia,1 Francesco Albano11Department of Emergency and Organ Transplantation (D.E.T.O.)...

Full description

Bibliographic Details
Main Authors: Tarantini F, Anelli L, Ingravallo G, Attolico I, Zagaria A, Russo Rossi A, Lospalluti L, Bufano T, Zanframundo G, Maiorano E, Specchia G, Albano F
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Cancer Management and Research
Subjects:
inhibitor tyrosine kinase
skin lesions
chronic myeloid leukemia
CD8+ lymphocytes
dasatinib;
Online Access:https://www.dovepress.com/skin-lesions-in-chronic-myeloid-leukemia-patients-during-dasatinib-tre-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/skin-lesions-in-chronic-myeloid-leukemia-patients-during-dasatinib-tre-peer-reviewed-article-CMAR

Similar Items